PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
16.49%
Similar revenue growth to CRK's 21.18%. Walter Schloss would investigate if similar growth reflects similar quality.
2.20%
Cost growth above 1.5x CRK's 1.29%. Michael Burry would check for structural cost disadvantages.
31.21%
Gross profit growth 1.25-1.5x CRK's 27.58%. Bruce Berkowitz would examine sustainability.
12.63%
Margin expansion exceeding 1.5x CRK's 5.28%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
38.78%
G&A growth above 1.5x CRK's 2.34%. Michael Burry would check for operational inefficiency.
No Data
No Data available this quarter, please select a different quarter.
-1.88%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
2.32%
Operating expenses growth while CRK reduces costs. John Neff would investigate differences.
2.27%
Total costs growth while CRK reduces costs. John Neff would investigate differences.
-3.25%
Interest expense reduction while CRK shows 48.94% growth. Joel Greenblatt would examine advantage.
-0.49%
D&A reduction while CRK shows 20.15% growth. Joel Greenblatt would examine efficiency.
-74.65%
EBITDA decline while CRK shows 132.07% growth. Joel Greenblatt would examine position.
14.46%
EBITDA margin growth below 50% of CRK's 115.15%. Michael Burry would check for structural issues.
134.02%
Operating income growth exceeding 1.5x CRK's 72.65%. David Dodd would verify competitive advantages.
129.20%
Operating margin growth exceeding 1.5x CRK's 77.43%. David Dodd would verify competitive advantages.
-851.22%
Other expenses reduction while CRK shows 133.92% growth. Joel Greenblatt would examine advantage.
148.15%
Pre-tax income growth 1.25-1.5x CRK's 111.86%. Bruce Berkowitz would examine sustainability.
141.33%
Pre-tax margin growth 1.25-1.5x CRK's 109.79%. Bruce Berkowitz would examine sustainability.
199.17%
Tax expense growth above 1.5x CRK's 112.72%. Michael Burry would check for concerning trends.
285.71%
Net income growth exceeding 1.5x CRK's 111.66%. David Dodd would verify competitive advantages.
259.42%
Net margin growth exceeding 1.5x CRK's 109.63%. David Dodd would verify competitive advantages.
282.76%
EPS growth exceeding 1.5x CRK's 111.06%. David Dodd would verify competitive advantages.
282.76%
Diluted EPS growth exceeding 1.5x CRK's 111.16%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
0.18%
Diluted share change of 0.18% while CRK is stable. Bruce Berkowitz would verify approach.